Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7815071

CCCCn1c(=O)c(-c2cn(CCCN)c3ccccc23)nc2ccccc21.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
KDM4E B2RXH2 2/20 0.48
HTT P42858 2/20 0.48
CYP2C9 P11712 3/20 0.46
CYP2C19 P33261 3/20 0.46
CYP1A2 P05177 2/20 0.46
GLA P06280 1/20 0.46
CYP2D6 P10635 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CAMK2D Q13557 5/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
TPSAB1 Q15661 2/20 0.43
CNR2 P34972 4/20 0.43
PIM1 P11309 1/20 0.42
CYP3A4 P08684 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7815291 0.94 CAMK2D (0.46) ALDH1A1CYP2C9CYP2C19CYP1A2CAMK2D
Trifluoroacetic Acid SCHEMBL8516338 0.90 ALDH1A1 (0.45) ALDH1A1KDM4EHTTCYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL7817667 0.89 CAMK2D (0.44) KDM4ECAMK2DPIM1
Trifluoroacetic Acid SCHEMBL7806936 0.89 CFTR (0.49) ALDH1A1CYP1A2CAMK2DUSP2
Trifluoroacetic Acid SCHEMBL7814551 0.88 USP2 (0.53) ALDH1A1KDM4EHTTCYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL7818314 0.88 CAMK2D (0.48) ALDH1A1KDM4EHTTRAB9ACAMK2D
Trifluoroacetic Acid SCHEMBL7814735 0.88 PDE4B (0.44) ALDH1A1CYP2C9CYP2C19CYP1A2NPC1
Trifluoroacetic Acid SCHEMBL8365255 0.88 MEN1 (0.42) ALDH1A1KDM4EHTTCYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL7817211 0.87 MAPT (0.43) ALDH1A1CYP2C9CYP2C19CYP1A2CAMK2D
SCHEMBL7806891 0.87 CAMK2D (0.53) ALDH1A1CYP2C9CYP2C19CYP1A2CAMK2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025043-A1 New pharmaceutical active compounds ASTRA AKTIEBOLAG, A SWEDEN CORPORATION 2001-09-27 US disclosed
US-6271231-B1 Pharmaceutically active compounds ASTRA AKTIEBOLAG (SE) 2001-08-07 US disclosed
EP-0929551-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS Astra Aktiebolag (publ) (SE) 1999-07-21 EP disclosed
WO-1998013368-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRA AKTIEBOLAG (PUBL) (SE) 1998-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025043-A1 New pharmaceutical active compounds CSNK1A1, CSNK1G1, CSNK2A1 ALDH1A1 2487/4885KDM4E 1621/4885HTT 4078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.